NCT00367016
- Conditions
- Allergic Rhinitis, Asthma, Atopic Dermatitis, +20 more
- Locations
-
- UC Davis Department of Dermatology Sacramento, California, United States
Clinical trial condition
Dermatitis, Atopic
Explore clinical trials studying Dermatitis, Atopic. Study availability and eligibility vary by location and protocol.
1,194 public trials
150 recruiting studies
Dermatitis, Atopic trial results
NCT02424253
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
- Locations
-
- Belgium Study Site Brussels, Belgium
- Belgium Study Site Leuven, Belgium
- Belgium Study Site Liège, Belgium
- German Study Site Goch, Germany
Completed
Phototherpy Versus Tapwater Iontophoresis for Management of Atopic Dermatitis in Children.
NCT04444726
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
- Locations
-
- Banha University Banhā, Egypt
NCT04900948
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
- Locations
-
- National Medical Research Center for Children's Health Moscow, Russia
NCT02975206
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +13 more
- Locations
-
- Study Site 332 Anniston, Alabama, United States
- Study Site 363 Birmingham, Alabama, United States
- Study Site 340 Hoover, Alabama, United States
- Study Site 364 Glendale, Arizona, United States
NCT02196324
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +11 more
- Locations
-
- Study Site 08 Bonn, Germany
- Study Site 06 Dresden, Germany
- Study Site 12 Düsseldorf, Germany
- Study Site 02 Frankfurt, Germany
NCT03619161
- Conditions
- Atopic Dermatitis, Atopic Dermatitis and Related Conditions, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +11 more
- Locations
-
- The University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
Completed
A Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis
NCT03443024
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
- Locations
-
- Clear Dermatology & Aesthetics Center Scottsdale, Arizona, United States
- Dermatology Trial Associates Bryant, Arkansas, United States
- Northwest Arkansas Clinical Trials Center Rogers, Arkansas, United States
- Center for Dermatology Clinical Research, Inc. Fremont, California, United States
Completed
Investigation of Efficacy of Secukinumab in Patients With Moderate to Serve Atopic Dermatitis
NCT03568136
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +11 more
- Locations
-
- Klinische Forschung Dresden GmbH Dresden, Germany
- Carl Gustav Carus University Hospital, Department of Dermatology Dresden, Germany
- SRH Wald-Klinikum Gera, Center for Clinical Studies Gera, Germany
- Hannover Medical School, Department for Dermatology, Allergy and Venereology Hanover, Germany
NCT04339985
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
- Locations
-
- UNION therapeutics Investigational Site 5 Pleven, Bulgaria
- UNION therapeutics Investigational Site 2 Sofia, Bulgaria
- UNION therapeutics Investigational Site 3 Sofia, Bulgaria
- UNION therapeutics Investigational Site 4 Sofia, Bulgaria